Skip to main content
Top
Published in: Journal of Cancer Research and Clinical Oncology 3/2009

01-03-2009 | Rapid Communication

The prevalence of microsatellite instability in head and neck squamous cell carcinoma

Authors: Harlinde De Schutter, Marijke Spaepen, Sofie Van Opstal, Vincent Vander Poorten, Erik Verbeken, Sandra Nuyts

Published in: Journal of Cancer Research and Clinical Oncology | Issue 3/2009

Login to get access

Abstract

Purpose

The present study aimed to use the most definitive available techniques to resolve controversy in the literature as to the prevalence of microsatellite instability (MSI) in head and neck squamous cell carcinoma (HNSCC).

Methods

Eighty patients with advanced HNSCC were enrolled in the study that examined 20 microsatellite markers with automatic fragment analysis. These markers included ones derived from the NCI reference panel and ones previously reported to detect MSI in HNSCC (HNSCC panel).

Results

Only one of 80 tumors could be considered positive for MSI. For this case, both panels showed MSI-High (8/10 positive markers for the NCI reference panel and 6/10 positive markers for the HNSCC panel). Qualitatively, the observed MSI could be classified as Type B MSI.

Conclusions

The present results indicate that MSI has a low prevalence in HNSCC.
Literature
go back to reference Boland CR, Thibodeau SN, Hamilton SR et al (1998) A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 58(22):5248–57PubMed Boland CR, Thibodeau SN, Hamilton SR et al (1998) A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 58(22):5248–57PubMed
go back to reference Maehara Y, Oda S, Sugimachi K (2001) The instability within: problems in current analyses of microsatellite instability. Mutat Res 461(4):249–263PubMed Maehara Y, Oda S, Sugimachi K (2001) The instability within: problems in current analyses of microsatellite instability. Mutat Res 461(4):249–263PubMed
go back to reference Oda S, Maehara Y, Ikeda Y et al (2005) Two modes of microsatellite instability in human cancer: differential connection of defective DNA mismatch repair to dinucleotide repeat instability. Nucl Acids Res 33(5):1628–1636. doi:10.1093/nar/gki303 PubMedCrossRef Oda S, Maehara Y, Ikeda Y et al (2005) Two modes of microsatellite instability in human cancer: differential connection of defective DNA mismatch repair to dinucleotide repeat instability. Nucl Acids Res 33(5):1628–1636. doi:10.​1093/​nar/​gki303 PubMedCrossRef
go back to reference Perucho M (1999) Correspondence re: C.R. Boland et al. A National Cancer Institute workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 58:5248–5257, 1998. Cancer Res 59(1):249–256 Perucho M (1999) Correspondence re: C.R. Boland et al. A National Cancer Institute workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 58:5248–5257, 1998. Cancer Res 59(1):249–256
go back to reference Umar A, Boland CR, Terdiman JP et al (2004) Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 96(4):261–268PubMedCrossRef Umar A, Boland CR, Terdiman JP et al (2004) Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 96(4):261–268PubMedCrossRef
Metadata
Title
The prevalence of microsatellite instability in head and neck squamous cell carcinoma
Authors
Harlinde De Schutter
Marijke Spaepen
Sofie Van Opstal
Vincent Vander Poorten
Erik Verbeken
Sandra Nuyts
Publication date
01-03-2009
Publisher
Springer-Verlag
Published in
Journal of Cancer Research and Clinical Oncology / Issue 3/2009
Print ISSN: 0171-5216
Electronic ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-008-0476-1

Other articles of this Issue 3/2009

Journal of Cancer Research and Clinical Oncology 3/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.